Skip to search.
 FTSE 100 Up 0.08%

Achillion Pharmaceuticals, Inc. (ACHN)

-NasdaqGS
9.10 Up 0.05(0.55%) 27 May 21:00
|After Hours: : 9.10 Up 0.00 (0.02%) 27 May 21:25
Prev Close:9.05
Open:9.06
Bid:N/A
Ask:9.24 x 1000
1y Target Est:9.40
Beta:1.97599
Earnings Date:8 Aug - 12 Aug (Est.)
Day's Range:8.96 - 9.16
52wk Range:5.57 - 10.95
Volume:912,630
Avg Vol (3m):1,469,880
Market Cap:1.24b
P/E (ttm):N/A
EPS (ttm):-0.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ACHN at this time.

Comparison

Symbol% ChgMkt Cap
ACHNUp 0.55%1.24b
GSKDown 0.79%103.84b
JNJUp 0.14%310.99b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):18.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.65
Quarterly EPS Est (Jun-16) :-0.15
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-0.79

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecule drug therapies for infectious diseases and immune system disorders in the United States and internationally. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback